Email ID
Password
Sign me in automatically next time
AMT suspends Glybera and plans 50% job cuts in restructuring moves

Following a negative opinion from the European Medicine's Agency's Committee for Medicinal Products for Human Use (CHMP) on its lead product, Glybera (alipogene tiparvovec) for the treatment of...
26 October 2011
Pial Ganguli

pial.ganguli@informa.com





Please Login to read the full article.
EVENTS
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36